Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis.
Kavish R PatidarMaria Guarnizo OrtizJames E Slaven IiLauren D NephewEduardo Vilar-GomezCarla D KettlerMarwan S GhabrilArchita P DesaiEric S OrmanNaga ChalasaniSamer GawriehPublished in: Hepatology communications (2023)
rAH develops in ~1 in 10 AH survivors and is associated with lower long-term survival. Medications for alcohol use disorder lower the risk for rAH and, therefore, could be a key preventative strategy to improve outcomes.